TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
180 Life Sciences ( (ATNF) ) has provided an update.
On August 12, 2025, 180 Life Sciences Corp., now known as ETHZilla, announced the initiation of its ETH accumulation strategy, revealing holdings of 82,186 ETH valued at approximately $349 million, alongside $238 million in USD cash equivalents. This strategic move, funded by proceeds from a recent PIPE offering and convertible notes, aims to enhance shareholder value through yield generation programs managed by Electric Capital, positioning ETHZilla as a leader in Ethereum treasury management.
More about 180 Life Sciences
180 Life Sciences, operating as ETHZilla, is transitioning from its origins as a biotechnology company to focus on software-enabled gaming and entertainment, alongside developing an institutional vehicle for Ether (ETH) accumulation. The company aims to become a benchmark for on-chain treasury management among public companies, leveraging partnerships with entities like Electric Capital to pursue innovative yield generation strategies.
Average Trading Volume: 2,557,574
Technical Sentiment Signal: Buy
Current Market Cap: $514.5M
Find detailed analytics on ATNF stock on TipRanks’ Stock Analysis page.